These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 2029002)
1. ASHP guidelines for selecting pharmaceutical manufacturers and suppliers. Am J Hosp Pharm; 1991 Mar; 48(3):523-4. PubMed ID: 2029002 [No Abstract] [Full Text] [Related]
2. Hospital pharmacists seek to control sales rep activities. Alt SJ Hosp Mater Manage; 1992 Apr; 17(4):2, 16. PubMed ID: 10170987 [No Abstract] [Full Text] [Related]
3. ASHP statement on the pharmacist's responsibility for distribution and control of drug products. Am J Hosp Pharm; 1992 Aug; 49(8):2009-10. PubMed ID: 1442848 [No Abstract] [Full Text] [Related]
4. Management of quality, capacity, and productivity at Merck. Nathan J; Venkataraman R Hosp Mater Manage Q; 1999 Feb; 20(3):64-9. PubMed ID: 10345635 [TBL] [Abstract][Full Text] [Related]
5. Guidelines for pharmacists and the pharmaceutical industry. The Canadian Society of Hospital Pharmacists. Dimens Health Serv; 1990 Nov; 67(8):14-6. PubMed ID: 2276520 [No Abstract] [Full Text] [Related]
6. VHA plans joint venture with suppliers to make, package products for members. Barkholz D Mod Healthc; 1985 Mar; 15(7):60. PubMed ID: 10317574 [No Abstract] [Full Text] [Related]
7. ASHP guidelines on hospital drug distribution and control (with references). Am J Hosp Pharm; 1980 Aug; 37(8):1097-103. PubMed ID: 7405941 [No Abstract] [Full Text] [Related]
9. Misrepresenting an ASHP practice standard for commercial purposes. Myers CE Am J Hosp Pharm; 1994 Sep; 51(17):2107-8. PubMed ID: 7985684 [No Abstract] [Full Text] [Related]
10. Quality assurance standards for purchasing and inventory control. Soares DP Am J Hosp Pharm; 1985 Mar; 42(3):610-20. PubMed ID: 3985026 [TBL] [Abstract][Full Text] [Related]
11. ASHP guidelines for the use of investigational drugs in organized health-care settings. Am J Hosp Pharm; 1991 Feb; 48(2):315-9. PubMed ID: 2003508 [No Abstract] [Full Text] [Related]
12. Assessment of vendors and drug-product selection. Dedrick SC; Eckel FM Am J Hosp Pharm; 1984 Apr; 41(4):703-8. PubMed ID: 6720713 [TBL] [Abstract][Full Text] [Related]
13. Marketing to the pharmacist. Zilz DA Med Mark Media; 1981 Jul; 16(7):8, 10, 14. PubMed ID: 10317131 [No Abstract] [Full Text] [Related]
14. Two cheers for the CMA's new guidelines on drug company-MD relations The CMA's MD-drug industry guidelines offer advice, nothing more. Rapp MS; Woollard R CMAJ; 1991 Dec; 145(11):1497-9. PubMed ID: 11649303 [No Abstract] [Full Text] [Related]
15. Hospital bans free drug samples. Charatan F West J Med; 2001 Apr; 174(4):236-7. PubMed ID: 11290668 [No Abstract] [Full Text] [Related]
16. Pharmaceutical scam: use audit to detect 'pyramid cube scheme'. Gardner JR Healthc Financ Manage; 1982 Sep; 36(9):72, 74. PubMed ID: 10317232 [No Abstract] [Full Text] [Related]
17. The PMAC code of marketing practices: time for improvement? Pharmaceutical Manufacturers Association of Canada. Desjardins JG CMAJ; 1997 Feb; 156(3):363-4. PubMed ID: 9033417 [TBL] [Abstract][Full Text] [Related]
18. Generic drug prices fall 7%-24%; groups sort out manufacturers. Bernstein T Hosp Mater Manage; 1989 Feb; 14(2):8-10. PubMed ID: 10318186 [No Abstract] [Full Text] [Related]
19. Securing the US pharmaceutical supply. Somberg JC Am J Ther; 2008; 15(3):197. PubMed ID: 18496255 [No Abstract] [Full Text] [Related]
20. Use caution when donating drugs, guidelines suggest. Riggs B CMAJ; 1990 Jan; 142(1):65-6. PubMed ID: 2293855 [No Abstract] [Full Text] [Related] [Next] [New Search]